Maja Strnad Cestar has been appointed as the new CEO

Upcoming Changes in Medis Leadership 

Martina Perharič, the current CEO of Medis, will transition to a new role as Chief Business Officer (CBO) of Pharmaceuticals, effective 1 August 2023. At the...

Discover the potential

Combining Forces to Reach Patients with Rare Diseases Across the Globe

World Orphan Drug Alliance (WODA) is a new global alliance of full-service regional distributors for orphan drugs. 

New partnership

Medis and PAION Have Signed Commercialization Agreement for Three Innovative Hospital Therapies

Medis will be an exclusive partner for the commercialization of three innovative products in 9 different markets across the CEE region.

Exclusive Partnership

Long-Term Partnership with Salix in the Therapeutic Area of Digestive Health

Medis has signed a long-term agreement with Salix for the commercialization of a new and innovative digestive health product in 11 different countries across...

Medis will Commercialize Orphan Drug NaMuscla® in Central and Eastern European Countries

Medis will initially focus on the commercialization of NaMuscla® in Croatia, Czech Republic, Hungary, Slovakia, and Slovenia.

We wish you a winning 2022

The Ode to the Winners was composed by Drago Ivanuša in November 2021 in honour of all the doctors and pharmacists who participate in the International Medis...